Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Merck & Co Inc MRK

Healthcare
Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for... see more

Recent & Breaking News (NYSE:MRK)

Merck Announces Third-Quarter 2014 Dividend

Business Wire May 27, 2014

Merck Animal Health Announces FDA Approval of BRAVECTO(TM) (fluralaner)

PR Newswire May 20, 2014

Merck and Endocyte Announce Withdrawal of Conditional Marketing Authorization Applications for Vintafolide and Companion Imaging Components, Etarfolatide and Intravenous (IV) Folic Acid in Europe

Business Wire May 19, 2014

Merck's Investigational Anti-PD1 Antibody, MK-3475, Active in Three Different Tumor Types: New Data to be Presented at the 2014 ASCO Annual Meeting

Business Wire May 14, 2014

Merck Signs Sale Agreement with Santen for Merck's Ophthalmology Products in Japan and Key Markets in Europe and Asia Pacific

Business Wire May 13, 2014

FDA Approves ZONTIVITY(TM) (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease

Business Wire May 12, 2014

AiCuris and Merck Announce Publication in New England Journal of Medicine of Phase 2 Clinical Trial Results of Investigational Antiviral Agent Letermovir in Bone Marrow Transplant Patients

Business Wire May 8, 2014

Merck Highlights Progress on Its Strategic Initiative to Sharpen Commercial and R&D Focus; Drive Growth and Productivity

Business Wire May 6, 2014

Merck Announces FDA Acceptance for Review of MK-3475 Biologics License Application for Advanced Melanoma

Business Wire May 6, 2014

Merck Announces Sale of Consumer Care Business to Bayer AG for $14.2 Billion

Business Wire May 6, 2014

Merck and Endocyte Announce Independent DSMB Recommends Vintafolide PROCEED Phase 3 Trial Be Stopped for Futility Following Interim Analysis

Business Wire May 2, 2014

Are Exosomes the Next PD-1 in Cancer Research?

Accesswire April 30, 2014

Merck KGaA: Form 8 (DD) - AZ Electronic Materials S.A.

Marketwired April 30, 2014

Merck Announces First-Quarter 2014 Financial Results

Business Wire April 29, 2014

Practice Fusion Teams with Merck on Population Health Management Initiative

PR Newswire April 28, 2014

Merck to Hold Investor Briefing at Boston Research Facility

Business Wire April 28, 2014

Merck KGaA: Form 8 (DD) - AZ Electronic Materials S.A.

Marketwired April 28, 2014

Merck KGaA: Form 8 (DD) - AZ Electronic Materials S.A.

Marketwired April 25, 2014

Merck and Award-Winning Actress S. Epatha Merkerson Challenge Americans with Type 2 Diabetes to Get to Their Goals

PR Newswire April 23, 2014

Merck KGaA: Form 8 (DD) - AZ Electronic Materials S.A.

Marketwired April 23, 2014